- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Prenetics appoints longevity expert Dr. Darshan Shah to board | 3 | Investing.com | ||
| Di | Prenetics Global Limited: Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors | 4 | GlobeNewswire (USA) | ||
| Di | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Di | Prenetics Global Limited: Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity | 463 | GlobeNewswire (Europe) | Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026... ► Artikel lesen | |
| So | Quant snapshot: IAMGOLD, Prenetics lead strong buys as Sol Strategies, Endava lag | 17 | Seeking Alpha | ||
| Fr | Prenetics Global Limited: Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder | 1 | GlobeNewswire (USA) | ||
| 11.02. | Roth/MKM initiates Prenetics stock with Buy rating on IM8 supplement success | 1 | Investing.com | ||
| 11.02. | Roth/MKM stuft Prenetics mit "Buy" ein - Erfolg von IM8-Nahrungsergänzungsmittel als Treiber | 1 | Investing.com Deutsch | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 06.01. | Prenetics divests 3PL distribution business in all-stock deal valued at up to $13M | 2 | Seeking Alpha | ||
| 05.01. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 31.12.25 | David Beckham's Prenetics halts $1B Bitcoin plan to focus on IM8 health brand | 1 | iNVEZZ.com | ||
| 30.12.25 | Prenetics halts Bitcoin purchases to focus on consumer health brand, IM8 | 2 | Seeking Alpha | ||
| 30.12.25 | Prenetics Global Limited: Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8 | 245 | GlobeNewswire (Europe) | Company's Capital and Strategic Focus Now Exclusively Focused on IM8 IM8 FY 2026 Revenue Projected to Reach $180 - $200 Million CHARLOTTE, N.C., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Prenetics Global... ► Artikel lesen | |
| 23.12.25 | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.12.25 | Prenetics Global Limited: Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure | 324 | GlobeNewswire (Europe) | CHARLOTTE, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and... ► Artikel lesen | |
| 11.12.25 | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 24.11.25 | Prenetics executives purchase $1.4 million in company stock | 1 | Investing.com | ||
| 24.11.25 | Prenetics executives buy $1.45M in company stock | 2 | Seeking Alpha | ||
| 24.11.25 | Prenetics-Management investiert 1,45 Millionen US-Dollar in eigene Aktien | 1 | Investing.com Deutsch | ||
| 24.11.25 | Prenetics Global Limited: Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million | 2 | GlobeNewswire (USA) |
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 663,60 | -2,01 % | Regeneron Pharmaceuticals, Inc.: Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy | 36 abstracts to be presented across Regeneron-invented therapies, including first-time Phase 3 presentations for two distinct investigational allergen-blocking antibodies for cat and birch allergies... ► Artikel lesen | |
| VIKING THERAPEUTICS | 25,655 | +5,97 % | Viking Therapeutics, Inc.: Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update | Conference call scheduled for 4:30 p.m. ET today
Oral VK2735 to Advance into Phase 3 for Obesity in 3Q26
Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity... ► Artikel lesen | |
| CANSINO BIOLOGICS | 3,556 | +0,91 % | CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines | DUBAI, Feb. 9, 2026 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO"; SSE: 688185, HKEX: 06185) has been invited to share the practices of innovative vaccine at the World Government Summit... ► Artikel lesen | |
| SINO BIOPHARM | 0,716 | +1,39 % | BofAS: SINO BIOPHARM Shows Positive Progress on 2 Drugs; Rating Reiterated at Buy | ||
| GUARDANT HEALTH | 89,50 | +0,52 % | What Makes Guardant Health (GH) a Good Healthcare Holding | ||
| GENSCRIPT BIOTECH | 1,341 | +3,67 % | GenScript USA: 'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week | PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech... ► Artikel lesen | |
| BIO-TECHNE | 50,000 | -0,99 % | Dividendenbekanntmachungen (13.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6571 EUR A10 NETWORKS INC US0021211018 0,06 USD 0,0505 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| INNOVENT BIOLOGICS | 9,750 | +1,04 % | Innovent Biologics: Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer | SAN FRANCISCO and SUZHOU, China, Feb. 12, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent",HKEX: 01801), a world-class biopharmaceutical company that develops... ► Artikel lesen | |
| QUANTUM-SI | 0,939 | 0,00 % | Quantum-Si Inc - 8-K, Current Report | ||
| SCILEX | 7,313 | +4,17 % | XFRA NEW INSTRUMENTS AVAILABLE ON 10.02.2026 | The following instruments on XETRA do have their first trading 10.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.02.2026
Aktien
1 CNE100006V73 Auntea Jenny (Shanghai)... ► Artikel lesen | |
| ORIGIN AGRITECH | 0,930 | +8,77 % | Origin Agritech Limited: Origin Agritech Announces Fiscal Year 2025 Results | Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025
BEIJING, Jan. 30, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or... ► Artikel lesen | |
| AKESO | 11,200 | -0,88 % | Akeso, Inc.: Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab | HONG KONG, Dec. 11, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 36,940 | +2,58 % | Harmony Bio granted FDA label expansion for Wakix in children with narcolepsy | ||
| QIAGEN | 41,350 | -3,62 % | BERENBERG stuft QIAGEN NV auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Qiagen von 46 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Inmitten der Übernahmespekulationen liefere der... ► Artikel lesen | |
| DISC MEDICINE | 65,56 | +16,82 % | Disc Medicine Inc: Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP | FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use... ► Artikel lesen |
PRENETICS GLOBAL LIMITED gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von -0,150 (-0,68 %) liegt der Kurs bei 21,800 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.